Erythropoetin

DRUG3 trials

Sponsors

Baylor College of Medicine, Nordic MDS Group, Drexel University College of Medicine

Conditions

Aortic Arch Hypoplasia or InterruptionChronic Myelomonocytic LeukemiaCongenital Heart DiseaseHead and Neck CancerHypoplastic Left Heart SyndromeMyelodysplastic SyndromeTransposition of the Great Arteries

Phase 1

Erythropoetin Neuroprotection for Neonatal Cardiac Surgery

CompletedNCT00513240

Baylor College of MedicineAortic Arch Hypoplasia or Interruption, Congenital Heart Disease, Hypoplastic Left Heart Syndrome +1

Start: 2006-09-30End: 2015-09-30Updated: 2020-02-07

Phase 2

Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

CompletedNCT01048034

Nordic MDS GroupChronic Myelomonocytic Leukemia, Myelodysplastic Syndrome

Start: 2010-01-31End: 2012-08-31Updated: 2013-10-29

Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer

CompletedNCT01467115

Drexel University College of MedicineHead and Neck Cancer

Start: 2010-03-31End: 2014-10-07Updated: 2017-05-09